Cytomx Therap
CTMX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Cytomx Therap(CTMX) predict that the Revenue is 10.26 M (-79.85%), Beat estimate;the EBIT is -19.67 M (-187%), Beat estimate;the EPS is -0.1 (-137%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B79.85%
0.00B90.80%
+0.01B10.95%
EBITExceed expectations
-0.02B186.96%
-0.02B200.40%
+0.00B13.44%
EPSExceed expectations
-0.1137.04%
-0.1266146.89%
+0.02669.85%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf